ArticleBlood cancer journal2016

Increased circulating VCAM-1 correlates with advanced disease and poor survival in patients with multiple myeloma: reduction by post-bortezomib and lenalidomide treatment.

E Terpos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.